loratadine has been researched along with Cancer of Lung in 3 studies
Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Osimertinib is a tyrosine kinase approved and effective in treating lung adenocarcinomas that have one of several common activating mutations in epidermal growth factor receptor." | 6.72 | OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs. ( Halatsch, ME; Kast, RE; Rosell, R, 2021) |
| "Osimertinib is a tyrosine kinase approved and effective in treating lung adenocarcinomas that have one of several common activating mutations in epidermal growth factor receptor." | 2.72 | OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs. ( Halatsch, ME; Kast, RE; Rosell, R, 2021) |
| "The patient had a relapsing dermatosis beginning about 6 months before the diagnosis of the lung cancer, characterised by pruritic, erythematous plaques located on the trunk and arms." | 1.46 | Wells syndrome associated with lung cancer. ( Brito, C; Carvalho, SD; Ferreira, O; Santos, RP, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kast, RE | 1 |
| Halatsch, ME | 1 |
| Rosell, R | 1 |
| Santos, RP | 1 |
| Carvalho, SD | 1 |
| Ferreira, O | 1 |
| Brito, C | 1 |
| Ellegaard, AM | 1 |
| Dehlendorff, C | 1 |
| Vind, AC | 1 |
| Anand, A | 1 |
| Cederkvist, L | 1 |
| Petersen, NHT | 1 |
| Nylandsted, J | 1 |
| Stenvang, J | 1 |
| Mellemgaard, A | 1 |
| Østerlind, K | 1 |
| Friis, S | 1 |
| Jäättelä, M | 1 |
1 review available for loratadine and Cancer of Lung
| Article | Year |
|---|---|
OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs.
Topics: Acrylamides; Adenocarcinoma of Lung; Aniline Compounds; Animals; Azithromycin; Carcinoma, Non-Small- | 2021 |
2 other studies available for loratadine and Cancer of Lung
| Article | Year |
|---|---|
Wells syndrome associated with lung cancer.
Topics: Administration, Topical; Biopsy; Cellulitis; Clobetasol; Dermatologic Agents; Eosinophilia; Humans; | 2017 |
Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment.
Topics: A549 Cells; Adult; Apoptosis; Astemizole; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cations | 2016 |